INS and diabetes mellitus: Clinical evidence supports their therapeutic value, with a randomized trial demonstrating that more than 50% of patients with suboptimal glycemic control on insulin lispro achieved insulin independence after transitioning to weekly albiglutide therapy, leading to improved outcomes in diabetes management [237].